Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Nicotine from smoking may worsen hidradenitis suppurativa by affecting immune function and promoting inflammation.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Ulcerative colitis can cause skin issues due to immune system problems.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Inflammation in hair follicles is a key risk factor for developing common baldness.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

The woman has a rare, harmless skin condition specific to pregnancy that causes itchy bumps and will go away after she gives birth.

Simvastatin reduces inflammation and promotes hair regrowth in alopecia areata.

Wound healing is complex and requires more research to enhance treatment methods.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

Aging changes skin cells, leading to different DNA methylation and gene activity, affecting cell metabolism and aging signs.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

A rare skin condition in a 17-year-old was diagnosed late, stressing the need for careful evaluation and genetic testing.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

A 9-year-old boy had a rare scalp condition usually seen in young men.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.